1 Market Overview of Acquired Orphan Blood Diseases Therapeutics |
|
1.1 Acquired Orphan Blood Diseases Therapeutiarket Overview |
|
| 1.1.1 Acquired Orphan Blood Diseases Therapeutics Product Scope | |
| 1.1.2 Market Status and Outlook | |
1.2 Global Acquired Orphan Blood Diseases Therapeutiarket Size Overview by Region 2015 VS 2020 VS 2026 |
|
1.3 Global Acquired Orphan Blood Diseases Therapeutiarket Size by Region (2015-2026) |
|
1.4 Global Acquired Orphan Blood Diseases Therapeutics Historic Market Size by Region (2015-2020) |
|
1.5 Global Acquired Orphan Blood Diseases Therapeutiarket Size Forecast by Region (2021-2026) |
|
1.6 Key Regions Acquired Orphan Blood Diseases Therapeutiarket Size YoY Growth (2015-2026) |
|
| 1.6.1 North America Acquired Orphan Blood Diseases Therapeutiarket Size YoY Growth (2015-2026) | |
| 1.6.2 Europe Acquired Orphan Blood Diseases Therapeutiarket Size YoY Growth (2015-2026) | |
| 1.6.3 China Acquired Orphan Blood Diseases Therapeutiarket Size YoY Growth (2015-2026) | |
| 1.6.4 Rest of Asia Pacific Acquired Orphan Blood Diseases Therapeutiarket Size YoY Growth (2015-2026) | |
| 1.6.5 Latin America Acquired Orphan Blood Diseases Therapeutiarket Size YoY Growth (2015-2026) | |
| 1.6.6 Middle East & Africa Acquired Orphan Blood Diseases Therapeutiarket Size YoY Growth (2015-2026) | |
2 Acquired Orphan Blood Diseases Therapeutiarket Overview by Type |
|
2.1 Global Acquired Orphan Blood Diseases Therapeutiarket Size by Type: 2015 VS 2020 VS 2026 |
|
2.2 Global Acquired Orphan Blood Diseases Therapeutics Historic Market Size by Type (2015-2020) |
|
2.3 Global Acquired Orphan Blood Diseases Therapeutics Forecasted Market Size by Type (2021-2026) |
|
2.4 Medication |
|
2.5 Bone Marrow Transplant |
|
2.6 Blood Transfusion |
|
2.7 Iron Therapy |
|
3 Acquired Orphan Blood Diseases Therapeutiarket Overview by Type |
|
3.1 Global Acquired Orphan Blood Diseases Therapeutiarket Size by Application: 2015 VS 2020 VS 2026 |
|
3.2 Global Acquired Orphan Blood Diseases Therapeutics Historic Market Size by Application (2015-2020) |
|
| 詳.情：http://www.5269660.cn/2/02/Global-Acquired-Orphan-Blood-Diseases-Therapeutics-Industry-Research-and-Trends-Forecast.html | |
3.3 Global Acquired Orphan Blood Diseases Therapeutics Forecasted Market Size by Application (2021-2026) |
|
3.4 Hospitals |
|
3.5 Clinics |
|
3.6 Others |
|
4 Global Acquired Orphan Blood Diseases Therapeutics Competition Analysis by Players |
|
4.1 Global Acquired Orphan Blood Diseases Therapeutiarket Size (Million US$) by Players (2015-2020) |
|
4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acquired Orphan Blood Diseases Therapeutics as of 2019) |
|
4.3 Date of Key Manufacturers Enter into Acquired Orphan Blood Diseases Therapeutiarket |
|
4.4 Global Top Players Acquired Orphan Blood Diseases Therapeutics Headquarters and Area Served |
|
4.5 Key Players Acquired Orphan Blood Diseases Therapeutics Product Solution and Service |
|
4.6 Competitive Status |
|
| 4.6.1 Acquired Orphan Blood Diseases Therapeutiarket Concentration Rate | |
| 4.6.2 Mergers & Acquisitions, Expansion Plans | |
5 Company (Top Players) Profiles and Key Data |
|
5.1 Company 1 |
|
| 5.1.1 Company 1 Profile | |
| 5.1.2 Company 1 Main Business and Company's Total Revenue | |
| 5.1.3 Company 1 Products, Services and Solutions | |
| 5.1.4 Company 1 Revenue (US$ Million) (2015-2020) | |
| 5.1.5 Company 1 Recent Developments | |
5.2 Company 2 |
|
| 5.2.1 Company 2 Profile | |
| 5.2.2 Company 2 Main Business and Company's Total Revenue | |
| 5.2.3 Company 2 Products, Services and Solutions | |
| 5.2.4 Company 2 Revenue (US$ Million) (2015-2020) | |
| 5.2.5 Company 2 Recent Developments | |
5.3 Company 3 |
|
| 5.5.1 Company 3 Profile | |
| 5.3.2 Company 3 Main Business and Company's Total Revenue | |
| 5.3.3 Company 3 Products, Services and Solutions | |
| 5.3.4 Company 3 Revenue (US$ Million) (2015-2020) | |
| 5.3.5 Company 4 Recent Developments | |
5.4 Company 4 |
|
| 5.4.1 Company 4 Profile | |
| 5.4.2 Company 4 Main Business and Company's Total Revenue | |
| 5.4.3 Company 4 Products, Services and Solutions | |
| 5.4.4 Company 4 Revenue (US$ Million) (2015-2020) | |
| 5.4.5 Company 4 Recent Developments | |
5.5 Company 5 |
|
| 5.5.1 Company 5 Profile | |
| 5.5.2 Company 5 Main Business and Company's Total Revenue | |
| 5.5.3 Company 5 Products, Services and Solutions | |
| 5.5.4 Company 5 Revenue (US$ Million) (2015-2020) | |
| 5.5.5 Company 5 Recent Developments | |
5.6 Company 6 |
|
| 5.6.1 Company 6 Profile | |
| 5.6.2 Company 6 Main Business and Company's Total Revenue | |
| 5.6.3 Company 6 Products, Services and Solutions | |
| 5.6.4 Company 6 Revenue (US$ Million) (2015-2020) | |
| 5.6.5 Company 6 Recent Developments | |
5.7 Company 7 |
|
| 5.7.1 Company 7 Profile | |
| 全球收購孤兒血液病治療行業研究和趨勢預測報告二零二零年至2026年 | |
| 5.7.2 Company 7 Main Business and Company's Total Revenue | |
| 5.7.3 Company 7 Products, Services and Solutions | |
| 5.7.4 Company 7 Revenue (US$ Million) (2015-2020) | |
| 5.7.5 Company 7 Recent Developments | |
5.8 Company 8 |
|
| 5.8.1 Company 8 Profile | |
| 5.8.2 Onconova Therapeutiain Business and Company's Total Revenue | |
| 5.8.3 Company 8 Products, Services and Solutions | |
| 5.8.4 Company 8 Revenue (US$ Million) (2015-2020) | |
| 5.8.5 Company 8 Recent Developments | |
5.9 Company 9 |
|
| 5.9.1 Company 9 Profile | |
| 5.9.2 Company 9 Main Business and Company's Total Revenue | |
| 5.9.3 Company 9 Products, Services and Solutions | |
| 5.9.4 Company 9 Revenue (US$ Million) (2015-2020) | |
| 5.9.5 Company 9 Recent Developments | |
5.10 Company 10 |
|
| 5.10.1 Company 10 Profile | |
| 5.10.2 Company 10 Main Business and Company's Total Revenue | |
| 5.10.3 Company 10 Products, Services and Solutions | |
| 5.10.4 Company 10 Revenue (US$ Million) (2015-2020) | |
| 5.10.5 Company 10 Recent Developments | |
6 North America Acquired Orphan Blood Diseases Therapeutics by Players and by Application |
|
6.1 North America Acquired Orphan Blood Diseases Therapeutiarket Size and Market Share by Players (2015-2020) |
|
6.2 North America Acquired Orphan Blood Diseases Therapeutiarket Size by Application (2015-2020) |
|
7 Europe Acquired Orphan Blood Diseases Therapeutics by Players and by Application |
|
7.1 Europe Acquired Orphan Blood Diseases Therapeutiarket Size and Market Share by Players (2015-2020) |
|
7.2 Europe Acquired Orphan Blood Diseases Therapeutiarket Size by Application (2015-2020) |
|
8 China Acquired Orphan Blood Diseases Therapeutics by Players and by Application |
|
8.1 China Acquired Orphan Blood Diseases Therapeutiarket Size and Market Share by Players (2015-2020) |
|
8.2 China Acquired Orphan Blood Diseases Therapeutiarket Size by Application (2015-2020) |
|
9 Rest of Asia Pacific Acquired Orphan Blood Diseases Therapeutics by Players and by Application |
|
9.1 Rest of Asia Pacific Acquired Orphan Blood Diseases Therapeutiarket Size and Market Share by Players (2015-2020) |
|
9.2 Rest of Asia Pacific Acquired Orphan Blood Diseases Therapeutiarket Size by Application (2015-2020) |
|
10 Latin America Acquired Orphan Blood Diseases Therapeutics by Players and by Application |
|
10.1 Latin America Acquired Orphan Blood Diseases Therapeutiarket Size and Market Share by Players (2015-2020) |
|
10.2 Latin America Acquired Orphan Blood Diseases Therapeutiarket Size by Application (2015-2020) |
|
11 Middle East & Africa Acquired Orphan Blood Diseases Therapeutics by Players and by Application |
|
11.1 Middle East & Africa Acquired Orphan Blood Diseases Therapeutiarket Size and Market Share by Players (2015-2020) |
|
11.2 Middle East & Africa Acquired Orphan Blood Diseases Therapeutiarket Size by Application (2015-2020) |
|
12 Acquired Orphan Blood Diseases Therapeutiarket Dynamics |
|
12.1 Industry Trends |
|
12.2 Market Drivers |
|
12.3 Market Challenges |
|
12.4 Porter's Five Forces Analysis |
|
13 Research Finding /Conclusion |
|
14 Methodology and Data Source |
|
14.1 Methodology/Research Approach |
|
| 14.1.1 Research Programs/Design | |
| 14.1.2 Market Size Estimation | |
| 14.1.3 Market Breakdown and Data Triangulation | |
14.2 Data Source |
|
| 全球收購孤兒血液病治療行業研究和趨勢預測報告二零二零年至2026年 | |
| 14.2.1 Secondary Sources | |
| 14.2.2 Primary Sources | |
14.3 Disclaimer |
|
14.4 Author List |
|
| List of Tables | |
| Table 1. Global Market Acquired Orphan Blood Diseases Therapeutiarket Size (US$ Million) Comparison by Region 2015 VS 2020 VS 2026 | |
| Table 2. Global Acquired Orphan Blood Diseases Therapeutiarket Size by Region (2015-2020) (US$ Million) | |
| Table 3. Global Acquired Orphan Blood Diseases Therapeutiarket Size Share by Region (2015-2020) | |
| Table 4. Global Acquired Orphan Blood Diseases Therapeutics Forecasted Market Size by Region (2021-2026) (US$ Million) | |
| Table 5. Global Acquired Orphan Blood Diseases Therapeutics Forecasted Market Size Share by Region (2021-2026) | |
| Table 6. Global Acquired Orphan Blood Diseases Therapeutiarket Size (US$ Million) by Type: 2015 VS 2020 VS 2026 | |
| Table 7. Global Acquired Orphan Blood Diseases Therapeutiarket Size by Type (2015-2020) (US$ Million) | |
| Table 8. Global Acquired Orphan Blood Diseases Therapeutics Revenue Market Share by Type (2015-2020) | |
| Table 9. Global Acquired Orphan Blood Diseases Therapeutics Forecasted Market Size by Type (2021-2026) (US$ Million) | |
| Table 10. Global Acquired Orphan Blood Diseases Therapeutics Revenue Market Share by Type (2021-2026) | |
| Table 11. Global Acquired Orphan Blood Diseases Therapeutiarket Size (US$ Million) by Application: 2015 VS 2020 VS 2026 | |
| Table 12. Global Acquired Orphan Blood Diseases Therapeutiarket Size by Application (2015-2020) (US$ Million) | |
| Table 13. Global Acquired Orphan Blood Diseases Therapeutics Revenue Market Share by Application (2015-2020) | |
| Table 14. Global Acquired Orphan Blood Diseases Therapeutics Forecasted Market Size by Application (2021-2026) (US$ Million) | |
| Table 15. Global Acquired Orphan Blood Diseases Therapeutics Revenue Market Share by Application (2021-2026) | |
| Table 16. Global Acquired Orphan Blood Diseases Therapeutics Revenue (US$ Million) by Players (2015-2020) | |
| Table 17. Global Acquired Orphan Blood Diseases Therapeutics Revenue Market Share by Players (2015-2020) | |
| Table 18. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acquired Orphan Blood Diseases Therapeutics as of 2019) | |
| Table 19. Date of Key Manufacturers Enter into Acquired Orphan Blood Diseases Therapeutiarket | |
| Table 20. Global Acquired Orphan Blood Diseases Therapeutics Top Players Headquarters and Area Served | |
| Table 21. Acquired Orphan Blood Diseases Therapeutics Product Solution and Service | |
| Table 22. Global Acquired Orphan Blood Diseases Therapeutianufacturers Market Concentration Ratio (CR5 and HHI) | |
| Table 23. Mergers & Acquisitions, Expansion Plans | |
| Table 24. Company 1 Basic Information List | |
| Table 25. Company 1 Description, Business Overview and Total Revenue (US$ Million) Generated in 2019 | |
| Table 26. Company 1 Acquired Orphan Blood Diseases Therapeutics Products, Services and Solutions | |
| Table 27. Revenue (Million US$) in Acquired Orphan Blood Diseases Therapeutics Business of Company 1 (2015-2020) | |
| Table 28. Company 1 Recent Developments | |
| Table 29. Company 2 Basic Information List | |
| Table 30. Company 2 Description, Business Overview and Total Revenue (US$ Million) Generated in 2019 | |
| Table 31. Company 2 Acquired Orphan Blood Diseases Therapeutics Products, Services and Solutions | |
| Table 32. Revenue (Million US$) in Acquired Orphan Blood Diseases Therapeutics Business of Company 2 (2015-2020) | |
| Table 33. Company 2 Recent Developments | |
| Table 34. Company 3 Basic Information List | |
| Table 35. Company 3 Description, Business Overview and Total Revenue (US$ Million) Generated in 2019 | |
| Table 36. Company 3 Acquired Orphan Blood Diseases Therapeutics Products, Services and Solutions | |
| Table 37. Revenue (Million US$) in Acquired Orphan Blood Diseases Therapeutics Business of Company 3 (2015-2020) | |
| Table 38. Company 3 Recent Developments | |
| Table 39. Company 4 Basic Information List | |
| Table 40. Company 4 Description, Business Overview and Total Revenue (US$ Million) Generated in 2019 | |
| Table 41. Company 4 Acquired Orphan Blood Diseases Therapeutics Products, Services and Solutions | |
| Table 42. Revenue (Million US$) in Acquired Orphan Blood Diseases Therapeutics Business of Company 4 (2015-2020) | |
| Table 43. Company 4 Recent Developments | |
| Table 44. Company 5 Basic Information List | |
| Table 45. Company 5 Description, Business Overview and Total Revenue (US$ Million) Generated in 2019 | |
| Table 46. Company 5 Acquired Orphan Blood Diseases Therapeutics Products, Services and Solutions | |
| Table 47. Revenue (Million US$) in Acquired Orphan Blood Diseases Therapeutics Business of Company 5 (2015-2020) | |
| quánqiú shōugòu gū'ér xiěyè bìng zhìliáo hángyè yánjiū hé qūshì yùcè bàogào èr líng èr líng nián zhì 2026 nián | |
| Table 48. Company 5 Recent Developments | |
| Table 49. Company 6 Basic Information List | |
| Table 50. Company 6 Description, Business Overview and Total Revenue (US$ Million) Generated in 2019 | |
| Table 51. Company 6 Acquired Orphan Blood Diseases Therapeutics Products, Services and Solutions | |
| Table 52. Revenue (Million US$) in Acquired Orphan Blood Diseases Therapeutics Business of Company 6 (2015-2020) | |
| Table 53. Company 6 Recent Developments | |
| Table 54. Company 7 Basic Information List | |
| Table 55. Company 7 Description, Business Overview and Total Revenue (US$ Million) Generated in 2019 | |
| Table 56. Company 7 Acquired Orphan Blood Diseases Therapeutics Products, Services and Solutions | |
| Table 57. Revenue (Million US$) in Acquired Orphan Blood Diseases Therapeutics Business of Company 7 (2015-2020) | |
| Table 58. Company 7 Recent Developments | |
| Table 59. Company 8 Basic Information List | |
| Table 60. Company 8 Description, Business Overview and Total Revenue (US$ Million) Generated in 2019 | |
| Table 61. Company 8 Acquired Orphan Blood Diseases Therapeutics Products, Services and Solutions | |
| Table 62. Revenue (Million US$) in Acquired Orphan Blood Diseases Therapeutics Business of Company 8 (2015-2020) | |
| Table 63. Company 8 Recent Developments | |
| Table 64. Company 9 Basic Information List | |
| Table 65. Company 9 Description, Business Overview and Total Revenue (US$ Million) Generated in 2019 | |
| Table 66. Company 9 Acquired Orphan Blood Diseases Therapeutics Products, Services and Solutions | |
| Table 67. Revenue (Million US$) in Acquired Orphan Blood Diseases Therapeutics Business of Company 9 (2015-2020) | |
| Table 68. Company 9 Recent Developments | |
| Table 69. Company 10 Basic Information List | |
| Table 70. Company 10 Description, Business Overview and Total Revenue (US$ Million) Generated in 2019 | |
| Table 71. Company 10 Acquired Orphan Blood Diseases Therapeutics Products, Services and Solutions | |
| Table 72. Revenue (Million US$) in Acquired Orphan Blood Diseases Therapeutics Business of Company 10 (2015-2020) | |
| Table 73. Company 10 Recent Developments | |
| Table 74. Global Acquired Orphan Blood Diseases Therapeutiarket Size by Type (2015-2020) (Million US$) | |
| Table 75. North America Acquired Orphan Blood Diseases Therapeutiarket Size by Players (2015-2020) (US$ Million) | |
| Table 76. North America Acquired Orphan Blood Diseases Therapeutiarket Size Share by Players (2015-2020) | |
| Table 77. North America Acquired Orphan Blood Diseases Therapeutiarket Size by Application (2015-2020) (US$ Million) | |
| Table 78. Europe Acquired Orphan Blood Diseases Therapeutiarket Size by Players (2015-2020) (US$ Million) | |
| Table 79. Europe Acquired Orphan Blood Diseases Therapeutiarket Size Share by Players (2015-2020) | |
| Table 80. Europe Acquired Orphan Blood Diseases Therapeutiarket Size by Application (2015-2020) (US$ Million) | |
| Table 81. China Acquired Orphan Blood Diseases Therapeutiarket Size by Players (2015-2020) (US$ Million) | |
| Table 82. China Acquired Orphan Blood Diseases Therapeutiarket Size Share by Players (2015-2020) (US$ Million) | |
| Table 83. China Acquired Orphan Blood Diseases Therapeutiarket Size by Application (2015-2020) (US$ Million) | |
| Table 84. Rest of Asia Pacific Acquired Orphan Blood Diseases Therapeutiarket Size by Players (2015-2020) (US$ Million) | |
| Table 85. Rest of Asia Pacific Acquired Orphan Blood Diseases Therapeutiarket Size Share by Players (2015-2020) (US$ Million) | |
| Table 86. Rest of Asia Pacific Acquired Orphan Blood Diseases Therapeutiarket Size by Application (2015-2020) (US$ Million) | |
| Table 87. Latin America Acquired Orphan Blood Diseases Therapeutiarket Size by Players (2015-2020) (US$ Million) | |
| Table 88. Latin America Acquired Orphan Blood Diseases Therapeutiarket Size Share by Players (2015-2020) (US$ Million) | |
| Table 89. Latin America Acquired Orphan Blood Diseases Therapeutiarket Size by Application (2015-2020) (US$ Million) | |
| Table 90. Middle East & Africa Acquired Orphan Blood Diseases Therapeutiarket Size by Players (2015-2020) (US$ Million) | |
| Table 91. Middle East & Africa Acquired Orphan Blood Diseases Therapeutiarket Size Share by Players (2015-2020) (US$ Million) | |
| Table 92. Middle East & Africa Acquired Orphan Blood Diseases Therapeutiarket Size by Application (2015-2020) (US$ Million) | |
| Table 93. Market Top Trends | |
| Table 94. Key Drivers: Impact Analysis (2021-2026) | |
| Table 95. Key Challenges | |
| Table 96. Research Programs/Design for This Report | |
| Table 97. Key Data Information from Secondary Sources | |
| Table 98. Key Data Information from Primary Sources | |
| List of Figures | |
| グローバルを買収孤児の血液疾患治療薬業界の研究動向予測レポート2020年から2026年 | |
| Figure 1. Global Acquired Orphan Blood Diseases Therapeutiarket Size (US$ Million) Status and Outlook (2015-2026) | |
| Figure 2. Global Acquired Orphan Blood Diseases Therapeutiarket Share by Regions: 2020 VS 2026 | |
| Figure 3. North America Acquired Orphan Blood Diseases Therapeutiarket Size (US$ Million) and Growth Rate (2015-2026) | |
| Figure 4. Europe Acquired Orphan Blood Diseases Therapeutiarket Size (US$ Million) and Growth Rate (2015-2026) | |
| Figure 5. China Acquired Orphan Blood Diseases Therapeutiarket Size (US$ Million) and Growth Rate (2015-2026) | |
| Figure 6. Rest of Asia Pacific Acquired Orphan Blood Diseases Therapeutiarket Size (US$ Million) and Growth Rate (2015-2026) | |
| Figure 7. Latin America Acquired Orphan Blood Diseases Therapeutiarket Size (US$ Million) and Growth Rate (2015-2026) | |
| Figure 8. Middle East & Africa Acquired Orphan Blood Diseases Therapeutiarket Size (US$ Million) and Growth Rate (2015-2026) | |
| Figure 9. Global Acquired Orphan Blood Diseases Therapeutiarket Share by Type in 2020 & 2026 | |
| Figure 10. Medication Market Size (US$ Million) YoY Growth (2015-2026) | |
| Figure 11. Bone Marrow Transplant Market Size (US$ Million) YoY Growth (2015-2026) | |
| Figure 12. Blood Transfusion Market Size (US$ Million) YoY Growth (2015-2026) | |
| Figure 13. Iron Therapy Market Size (US$ Million) YoY Growth (2015-2026) | |
| Figure 14. Global Acquired Orphan Blood Diseases Therapeutiarket Size Share by Application in 2020 & 2026 | |
| Figure 15. Acquired Orphan Blood Diseases Therapeutiarket Size (US$ Million) and Growth Rate in Hospitals (2015-2020) | |
| Figure 16. Acquired Orphan Blood Diseases Therapeutiarket Size (US$ Million) and Growth Rate in Clinics (2015-2020) | |
| Figure 17. Acquired Orphan Blood Diseases Therapeutiarket Size (US$ Million) and Growth Rate in Others (2015-2020) | |
| Figure 18. Acquired Orphan Blood Diseases Therapeutiarket Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 | |
| Figure 19. Global Top 5 and Top 10 Players Acquired Orphan Blood Diseases Therapeutiarket Share in 2019 | |
| Figure 20. Europe Acquired Orphan Blood Diseases Therapeutics Revenue Market Share by Application (2015-2020) | |
| Figure 21. China Acquired Orphan Blood Diseases Therapeutics Revenue Market Share by Application (2015-2020) | |
| Figure 22. Rest of Asia Pacific Acquired Orphan Blood Diseases Therapeutics Revenue Market Share by Application (2015-2020) | |
| Figure 23. Latin America Acquired Orphan Blood Diseases Therapeutics Revenue Market Share by Application (2015-2020) | |
| Figure 24. Middle East & Africa Acquired Orphan Blood Diseases Therapeutics Revenue Market Share by Application (2015-2020) | |
| Figure 25. Porter's Five Forces Analysis | |
| Figure 26. Bottom-up and Top-down Approaches for This Report | |
| Figure 27. Data Triangulation | |
……
如需購買《Global Acquired Orphan Blood Diseases Therapeutics Industry Research and Trends Forecast Report 2020-2026》，編號：2753022
請您致電：400 612 8668、010-6618 1099、66182099、66183099
或Email至：KF@Cir.cn 【網上訂購】 ┊ 下載《訂購協議》 ┊ 了解“訂購流程”
請您致電：400 612 8668、010-6618 1099、66182099、66183099
或Email至：KF@Cir.cn 【網上訂購】 ┊ 下載《訂購協議》 ┊ 了解“訂購流程”
京公網安備 11010802027365號